BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing, China. Their priority is providing the highest quality, FDA-compliant services at an affordable cost. Their clients are over 40 pharmaceutical and biotechnology companies, and their services span the entire range of drug discovery and development, from discovery chemistry, through pharmacology and drug safety and evaluation, to clinical trials. Today, BioDuro is working with 10 of the 12 largest pharmaceutical companies in the world.
Molecular Response is an oncology research platform that comprises the largest collection of viable tumor specimens.
Formex
Acquisition in 2015
Formex LLC specializes in pharmaceutical contract development and manufacturing services, primarily focusing on oral and topical dosage forms. The company offers a range of services including pre-formulation, formulation development, analytical method development, and analytical testing. It also engages in pre-clinical manufacturing and current good manufacturing practice (cGMP) clinical trial manufacturing for early-phase clinical studies, as well as small-scale production of cytotoxic and highly potent compounds. Founded in 1996 and based in San Diego, California, Formex was formerly known as Formulation Technologies, L.L.C. It underwent a name change following its acquisition by Biotechnology Investment Group LLC, and currently operates as a subsidiary of BioDuro, LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.